The Kotak Nifty 100 Low Vol 30 ETF, managed by Kotak Mahindra Asset Management Company, aims to replicate the NIFTY 100 Low Volatility 30 Index, focusing on low volatility investments.

This fund employs a passive investment strategy designed to track the NIFTY 100 Low Volatility 30 TRI, ensuring that its performance aligns closely with the benchmark index.

The portfolio showcases a concentration in Pharmaceuticals and Biotechnology, with top holdings like DR REDDYS LABORATORIES LTD. at 3.52% and a diversified sector allocation across IT, Automobiles, and Banks.

Over the past year, the fund has seen a decline of 6.0%, while the three-year CAGR stands at an impressive 17.3%, reflecting strong long-term performance despite recent volatility.

With an AUM of ₹178.99 Cr and a low expense ratio of 0.09%, the fund is accessible through major exchanges, supporting liquidity and efficient trading for investors.